Results 111 to 120 of about 1,915,304 (214)

First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP Study. [PDF]

J Clin Med, 2023
van Veelen A, Küçük IT, Fuentes FH, Kahsay Y, Garcia-Garcia HM, Delewi R, Beijk MAM, den Hartog AW, Grundeken MJ, Vis MM, Henriques JPS, Claessen BEPM.   +11 more
europepmc   +1 more source

Comparisons of drug-eluting balloon versus drug-eluting stent for the treatment of cancer patients presenting with acute myocardial infarction. [PDF]

Eur J Med Res, 2023
Yang YX, Zhang HP, Li C, Fu Y, He KZ, Liu XM, Wang HJ, Xia K, Xu L, Zhong JC, Chen ML, Wang LF.   +11 more
europepmc   +1 more source

A case of vasculitis after paclitaxel drug-coated balloon angioplasty

JAAD Case Reports, 2022
Kelly Hawkins, BS, Rithu Srikantha, MD, Lauren Penn, MD, Amit Kakkar, MD, Jason Cohen, MD, Beth N. Mclellan, MD   +5 more
doaj   +1 more source

Bioabsorbable Endovascular Adhesive Tape (BEAT) for Improving Vascular Regeneration

Advanced Science
The drug‐coated balloons (DCBs) provide a combination therapy of balloon angioplasty and anti‐proliferative drug delivery to target lesions, thereby facilitating the appealing concept of leaving nothing behind.
Jiarong Wang, Jing Wang, Xinyi Li, Bo Yu, Yiduo Chen, Yirong Guo, Honglin Qian, Meng Hu, Haoyang Liu, Wenhui Liu, Han Xu, Kefeng Ren, M. Cristina L. Martins, Jian Ji   +13 more
doaj   +1 more source

Drug-eluting, balloon-expandable, bioresorbable vascular scaffolds reduce neointimal thickness and stenosis in an animal model of percutaneous peripheral intervention. [PDF]

JVS Vasc Sci, 2023
El Khoury R, Tzvetanov I, Estrada EA, McCarroll E, Goor JB, Guy LG, Laflamme M, Schwartz LB.   +7 more
europepmc   +1 more source

Paclitaxel-based devices in subintimal versus intraluminal angioplasty for chronic total occlusion of the femoropopliteal artery

JVS-Vascular Insights
Objective: Chronic total occlusion (CTO) of the femoropopliteal artery lesion is a common manifestation of symptomatic lower limb atherosclerosis. However, femoropopliteal chronic total occlusion (FP-CTO) lesions remain a major challenge in endovascular ...
Taro Kimura, MD, Toshitaka Okabe, MD, PhD, Hirotoshi Sato, MD, Toshihiko Matsuda, MD, Daiki Kato, MD, Yui Koyanagi, MD, Takeshi Okura, MD, Yuma Gibo, MD, Yuki Ito, MD, Shigehiro Ishigaki, MD, Tatsuki Fujioka, MD, Suguru Shimazu, MD, Yuji Oyama, MD, PhD, Naoei Isomura, MD, PhD, Masahiko Ochiai, MD, PhD   +14 more
doaj   +1 more source

Comparisons of Drug-Eluting Balloon versus Drug-Eluting Stent in the Treatment of Young Patients with Acute Myocardial Infarction. [PDF]

J Cardiovasc Dev Dis, 2023
Yang YX, He KZ, Li JY, Fu Y, Li C, Liu XM, Wang HJ, Chen ML, Su PX, Xu L, Wang LF.   +10 more
europepmc   +1 more source

Drug-eluting stent: a review and update

, 2005
Thein Htay, Ming W LiuDivision of Cardiovascular Medicine, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USAAbstract: The development of stent has been a major advance in the treatment of obstructive
Ming W Liu, Thein Htay
core  

Kissing drug eluting balloons for in-stent restenosis complicating bifurcations treated with drug-eluting stents.

, 2011
The management of in-stent restenosis (ISR) complicating bifurcation lesions is technically challenging and implant of further stents may not be feasible.
Doshi, Sagar, Raja, Y, Townend, Jonathan
core   +1 more source

Hybrid rotablation and drug-eluting balloon strategy. [PDF]

Cardiovasc J Afr, 2021
Vachiat A, Ntsekhe M, Hellig F.
europepmc   +1 more source